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Introduction
RNA transport and localization are important means in the con-
trol of gene expression in eukaryotic cells (Dahm and Kiebler, 
2007). In neurons, RNA transport to dendritic and axonal do-
mains  is  considered  an  essential  underpinning  of  neuronal 
functionality and plasticity (Mohr et al., 2001; Smith, 2004; 
Dahm et al., 2007; Miyashiro et al., 2009). Fundamental to neu-
ronal RNA transport mechanisms are cis-acting spatial codes 
that specify intracellular delivery destinations and trans-acting 
factors that decode such information for the cellular transport 
machinery (Blichenberg et al., 1999, 2001; Mohr and Richter, 
2003; Shan et al., 2003; Muslimov et al., 2006; Bramham and 
Wells,  2007;  Jambhekar  and  Derisi,  2007). Although  the   
information contained in RNA spatial destination codes is 
derived from genomic nucleotide sequences, decoding requires 
recognition of the code “gestalt” (the overall RNA motif struc-
ture representing the code) by trans-acting protein factors 
(Smith, 2004).
Eukaryotic RNA targeting motifs are diverse and co-
operate with various trans-acting factors for decoding (Eberwine 
et al., 2002; Bramham and Wells, 2007; Jambhekar and Derisi, 
2007). RNA motif structures that specify intracellular targeting 
are known as spatial destination codes, zip codes, or targeting 
elements. In neurons, the synapto-dendritic delivery of select 
mRNAs and regulatory RNAs is a prerequisite for translation at 
the synapse, and thus an important determinant of local protein 
synthetic output (Kindler et al., 2005; Dahm et al., 2007). One 
of the key trans-acting factors that recognize dendritic targeting 
elements (DTEs) in neuronal RNAs is heterogeneous nuclear 
ribonucleoprotein A2 (hnRNP A2; Shan et al., 2003; Smith, 
2004; Muslimov et al., 2006; Gao et al., 2008). Interactions of 
trans-acting factors with DTE spatial codes are the principal de-
terminants of neuronal RNA transport specificities. As a conse-
quence, they define synaptic RNA repertoires and thus control 
the spectrum of local protein synthetic capacity.
Fragile X–associated tremor/ataxia syndrome (FXTAS) is 
precipitated by CGG triplet repeat expansion in the 5 untrans-
lated region (UTR) of fragile X mental retardation 1 (FMR1) 
I
n neurons, regulation of gene expression occurs in 
part through translational control at the synapse. A 
fundamental requirement for such local control is the 
targeted delivery of select neuronal mRNAs and regula-
tory RNAs to distal dendritic sites. The nature of spatial 
RNA  destination  codes,  and  the  mechanism  by  which 
they are interpreted for dendritic delivery, remain poorly 
understood. We find here that in a key dendritic RNA 
transport pathway (exemplified by BC1 RNA, a dendritic 
regulatory RNA, and protein kinase M  [PKM] mRNA,   
a dendritic mRNA), noncanonical purine•purine nucleo-
tide  interactions  are  functional  determinants  of  RNA   
targeting  motifs.  These  motifs  are  specifically  recog-
nized by heterogeneous nuclear ribonucleoprotein A2 
(hnRNP A2), a trans-acting factor required for dendritic 
delivery. Binding to hnRNP A2 and ensuing dendritic   
delivery  are  effectively  competed  by  RNAs  with  CGG   
triplet repeat expansions. CGG repeats, when expanded in 
the 5 untranslated region of fragile X mental retarda-
tion 1 (FMR1) mRNA, cause fragile X–associated tremor/
ataxia syndrome. The data suggest that cellular dysregu-
lation observed in the presence of CGG repeat RNA may 
result from molecular competition in neuronal RNA trans-
port pathways.
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noncanonical G•A base pairs, an adjacent internal loop of variable 
geometry, and flanking standard WC base pairs, typically of the   
GC type (Lescoute et al., 2005; Muslimov et al., 2006). GA   
motifs are dimorphic and can alternate between an extended and 
a kinked (kink-turn or K-turn [KT]) conformation (Goody et al., 
2004; Tiedge, 2006; Schroeder et al., 2010). Secondary struc-
tures of GA motifs used in this work are shown in Fig. S1.
We performed EMSA analysis with recombinant hnRNP 
A2 to probe interactions of this trans-acting factor with RNA 
targeting motifs. Fig. 1 shows that wild type (WT) BC1 RNA 
was shifted to lower mobility by recombinant hnRNP A2. In 
clear contrast, a mutant BC1 RNA in which noncanonical G•A 
base pairs in the apical GA motif had been converted into stan-
dard WC pairs failed to interact with hnRNP A2 (Fig. 1 A; see 
Fig. S1 for GA motif mutants used.) These data indicate that 
noncanonical nucleotide interactions in the 5 BC1 GA motif 
are indispensable for recognition by hnRNP A2.
We next examined interactions of hnRNP A2 with PKM 
mRNA. PKM is a persistently active synaptic kinase that plays 
an essential role in long-term memory maintenance (Pastalkova 
et al., 2006; Serrano et al., 2008). We have previously reported 
that a 44-nucleotide stem-loop structure in the 3 UTR of PKM 
mRNA is required for distal dendritic targeting (Muslimov et al., 
2004). We subsequently hypothesized, on the basis of structural 
similarities,  that  this  stem-loop  harbors  a  targeting-relevant 
noncanonical GA motif (Muslimov et al., 2006; Tiedge, 2006). 
We now show that PKM mRNA binds specifically to hnRNP 
A2 (Fig. 1). We generated two PKM mRNA mutants in which 
the 44-nucleotide stem-loop structure in the 3 UTR was altered 
such that the tandem G•A pairs and the adjacent asymmetric 
internal loop motif were converted to canonical WC base pairs 
(WC mutant long and WC mutant short; Fig. S1). Neither of 
these canonical conversion mutants displayed any detectable 
binding to hnRNP A2 (WC mutant long shown in Fig. 1 B; WC 
mutant short data not depicted). The results indicate that a non-
canonical GA motif in a 3 UTR stem-loop structure of PKM 
mRNA is specifically recognized by hnRNP A2.
BC200 RNA is the primate functional analogue of rodent 
BC1 RNA (Tiedge et al., 1993; Lin et al., 2008). The two RNA 
genes are not orthologues, as their respective phylogenetic pedi-
grees are distinct (Martignetti and Brosius, 1993a,b). For this 
reason, it was necessary to examine BC200 RNA, next to BC1 
RNA, for its capacity to interact with hnRNP A2. Fig. 1 shows 
that hnRNP A2 binding capacities to BC200 and to BC1 RNAs 
were  indistinguishable.  (Analogously  to  BC1  RNA,  BC200 
RNA is also transported to distal dendritic domains; Fig. S2).
As a positive control in our EMSA analysis, we included 
myelin basic protein (MBP) mRNA, as it has previously been 
shown to interact with hnRNP A2 (Hoek et al., 1998; Munro et al., 
1999; Shan et al., 2000). This finding was replicated in our assay 
(Fig. 1). In a negative control, we probed binding of BC1 RNA 
and PKM mRNA to eukaryotic initiation factor 4G (eIF4G), 
an RNA-binding protein that interacts with mRNAs during the 
initiation phase of translation (Gingras et al., 1999; Pestova   
et al., 2007). For this purpose, we used the central, RNA-binding 
domain of eIF4G, as described previously (Pestova et al., 1996). 
The results show that eIF4G failed to produce a shift of BC1 
mRNA (Jacquemont et al., 2007; Brouwer et al., 2009; Hagerman 
et al., 2010). At 55–200 repeats (referred to as premutation), 
CGG triplets appear to cause gain-of-function RNA toxicity 
that results in cellular dysregulation (Jacquemont et al., 2007; 
Brouwer et al., 2009; Hagerman et al., 2010). CGG premuta-
tions may cause FXTAS, a late-onset neurodegenerative dis-
order (Jin et al., 2003) characterized by cognitive decline and 
motor disorders, and may also give rise to neurodevelopmental 
impairments with features resembling mild fragile X syndrome 
(FXS) or autism (Jacquemont et al., 2007; Hagerman et al., 
2010). We noted that analogous to DTEs of the GA motif sub-
type (Muslimov et al., 2006), CGG RNA repeats form stem 
loops that interact with hnRNP A2 (Sofola et al., 2007; Swanson 
and Orr, 2007). In further analogy, both GA-type DTEs and 
CGG  repeat  stem  loops  are  characterized  by  noncanonical 
(non–Watson Crick [non-WC]) purine•purine base interactions 
(Napierala et al., 2005; Muslimov et al., 2006; Tiedge, 2006; 
Zumwalt et al., 2007; Sobczak et al., 2010). Given their poten-
tially  equivalent  noncanonical,  hnRNP  A2–interacting  RNA 
motif content, we hypothesized that GA targeting motifs and 
CGG repeat stem-loops compete with each other for binding to 
trans-acting factor hnRNP A2.
Here we dissect the molecular basis of GA motif recogni-
tion by hnRNP A2, and the consequences of CGG versus GA 
motif competition in A2 recognition and dendritic targeting. 
Working with a representative of dendritic regulatory RNAs, 
BC1 RNA (Iacoangeli et al., 2010), and with a representative of 
dendritic mRNAs, PKM mRNA (Pastalkova et al., 2006; Serrano 
et al., 2008), we show that noncanonical structural motifs are 
critical for recognition and targeting. We found that CGG re-
peats compete with the BC1 GA motif for an essential targeting 
resource, hnRNP A2, resulting in impaired dendritic delivery. 
The data implicate RNA competition in disease-relevant neuro-
nal transport mechanisms.
Results
Interaction of hnRNP A2 with  
targeted RNAs
In this work, we sought to establish principles and the signifi-
cance of hnRNP A2 interactions with spatial codes in dendriti-
cally targeted neuronal RNAs. To this end, we first examined 
binding of hnRNP A2 to prototypical dendritic RNAs using 
quantitative electrophoretic mobility shift assays (EMSAs) with 
recombinant protein (Ryder et al., 2008; Chao et al., 2010). We 
focused on RNAs with spatial codes that we had previously pre-
dicted to be recognized by hnRNP A2 (Muslimov et al., 2006; 
Tiedge, 2006).
Regulatory BC1 RNA, a non-protein-coding small cyto-
plasmic RNA (scRNA), is an effector of translational control in 
neurons (Wang et al., 2002, 2005; Kondrashov et al., 2005; Lin 
et al., 2008; Iacoangeli et al., 2010). BC1 RNA is specifically 
targeted to distal dendritic domains (Muslimov et al., 1997, 
2006), and we have previously shown that a noncanonical GA 
motif in the apical part of the 5 BC1 stem loop domain is re-
sponsible for distal dendritic targeting (Muslimov et al., 2006). 
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High-affinity binding of hnRNP A2 to the 
BC1 GA motif
What is the binding affinity of hnRNP A2 for BC1 RNA? To 
establish equilibrium binding constants, we used quantita-
tive EMSA analysis to titrate the binding partners, measur-
ing the fraction of bound BC1 RNA as a function of hnRNP 
A2 protein concentration (Fig. 2 A). The equilibrium dissocia-
tion constant (Kd) was then calculated by fitting the data to 
the Hill equation, as described previously (Ryder et al., 2008; 
Chao et al., 2010). This analysis revealed a Kd of 8.2 nM, 
which indicates that BC1 RNA binds with high affinity to 
hnRNP A2.
Figure  1.  Dendritically  transported  BC1 
RNA and PKM mRNA interact with hnRNP 
A2. EMSA experiments were performed using   
native  PAGE.  (A  and  B)  BC1  RNA  and 
PKM  mRNA  bind  to  recombinant  hnRNP 
A2.  EMSA  experiments  revealed  shifts  to 
lower mobility as a result of binding of radio-
labeled RNAs to the protein. (A) Gel shifts 
induced by hnRNP A2 were observed with 
BC1 RNA, BC200 RNA, PKM mRNA, and 
MBP mRNA. For BC1 RNA and PKM mRNA, 
derivatives were used in which the noncanon-
ical GA motif had been converted to canoni-
cal WC base pairing. Such WC mutants, in 
contrast to the respective WT species, failed 
to interact with hnRNP A2 (A and B; only 
bound RNAs are shown in B). For secondary 
structures of WT and WC mutant motifs in 
BC1 RNA and PKM mRNA, see Fig. S1. The 
PKM mRNA WC mutant used in B was vari-
ant long. (C and D) BC1 RNA, BC200 RNA, 
and PKM mRNA are recognized by hnRNP 
A2 in brain extracts. (C) An antibody specific 
for hnRNP A2 (Ma et al., 2002) produced a 
supershift with BC1 RNA, BC200 RNA, and 
PKM mRNA. Shifted and supershifted bands 
are shown. (D) Recognition of PKM mRNA 
by hnRNP A2 in brain extracts depends on a 
noncanonical motif structure in a 3 UTR stem 
loop. WT PKM mRNA was supershifted by 
antibodies  against  hnRNP  A2;  in  contrast, 
WC mutant PKM mRNAs were not. Load-
ing (C and D): 1, RNAs; 2, RNAs plus brain 
extract; 3, RNAs plus brain extract plus anti-
A2 antibody.
RNA  and  PKM  mRNA  to  lower  mobilities,  in  contrast  to 
hnRNP A2, which clearly did (Fig. S3).
For independent corroboration of the EMSA data, we 
performed supershift experiments with antibodies specific for 
hnRNP A2 (Ma et al., 2002) using established techniques with 
rat brain extracts (Wang et al., 2002). As shown in Fig. 1 (C and D), 
BC1  RNA,  BC200  RNA,  and  PKM  mRNA  were  super-
shifted to lower mobilities by anti-hnRNP A2 antibodies in rat 
brain extracts. We conclude, on the basis of the combined data, 
that  trans-acting  factor  hnRNP A2  specifically  recognizes 
targeting-determinant noncanonical GA motifs in the dendritic 
RNAs examined.JCB • VOLUME 194 • NUMBER 3 • 2011   444
motif in the 5 BC1 domain is required for high-affinity binding 
to hnRNP A2.
Previous work has indicated that at sufficiently high con-
centrations of Mg
2+ ions, the apical 5 BC1 GA motif adopts the 
conformation of a KT motif (Muslimov et al., 2006). KT motifs 
We next used BC1 RNA in which the 5 GA motif has 
been converted to canonical base pairing (Fig. S1). Titration 
with hnRNP A2 did not reveal any indication of binding, even if 
excessively high protein concentrations (up to 50 µM) were 
used (Fig. 2 B). We conclude that an intact noncanonical GA 
Figure 2.  High-affinity binding of dendritic BC1 RNA to hnRNP A2 is modulated by Mg
2+ and Ca
2+ ions. Binding affinities were established by quantitative 
EMSA using native PAGE. WT BC1 RNA (A) and WC mutant BC1 RNA (B) were titrated with increasing concentrations of hnRNP A2 in the presence of 
10 mM MgCl2. Although a Kd of 8.2 nM was obtained for WT BC1 RNA, no equilibrium constant could be established for WC mutant BC1 RNA, as no 
binding was observed even at maximal hnRNP A2 concentrations. (C) Binding affinity of BC1 RNA to hnRNP A2 is dependent on the concentration of 
Mg
2+ ions. The following equilibrium dissociation constants were obtained: 25 mM MgCl2, Kd = 3.5 nM; 10 mM MgCl2, Kd = 8.2 nM; 5 mM MgCl2, Kd =   
520 nM; 2.5 mM MgCl2, Kd = 980 nM. (D) Binding of BC1 RNA to hnRNP A2 is modulated by Ca
2+ ion concentrations. Dissociation constants: 10 mM 
CaCl2, Kd = 0.6 nM; 5 mM CaCl2, Kd = 1.0 nM; 1 mM CaCl2, Kd = 210 nM; 0.5 mM CaCl2, Kd = 250 nM; 0.1 mM CaCl2, Kd = 380 nM.445 RNA codes in neuronal targeting • Muslimov et al.
We also examined whether application of A2 antisense 
oligonucleotides impacted the somato-dendritic localization of 
endogenous BC1 RNA. We first performed in situ hybridization 
experiments to confirm that endogenous BC1 RNA is located to 
somato-dendritic  domains  of  sympathetic  neurons  in  culture 
(Fig. 4, A and B), which is analogous to the previously reported 
localization in hippocampal neurons in culture (Muslimov et al., 
1998). Subsequent experiments, shown in Fig. 4 (C and D), re-
vealed no significant changes in dendritic localization of endog-
enous BC1 RNA after a 1-h exposure of sympathetic neurons to 
A2 antisense oligonucleotides. In contrast, a substantial decrease 
of dendritic (and an increase of somatic) levels of endogenous 
BC1 RNA was observed after 24 h in the presence of A2 anti-
sense oligonucleotides (Fig. 4, E–G). The data thus suggest that 
interference with dendritic transport of endogenous BC1 RNA 
does not seem to result in immediate reductions of dendritic 
RNA levels, as local reservoirs of preexisting RNAs are not rap-
idly depleted. Over time, however, dendritic levels decline as 
local preexisting RNAs are not being replenished.
For  PKM  mRNA,  a  44-nt  stem-loop  structure  in  the 
3 UTR is required for distal dendritic targeting (Muslimov   
et al., 2004). We have now shown that a noncanonical GA 
motif within this structure is specifically recognized by hnRNP 
A2 (Fig. 1). Is this motif, and recognition by hnRNP A2, re-
quired for distal dendritic delivery? We performed two sets of 
experiments to address these questions. First, we probed den-
dritic transport of PKM mRNA in cultured neurons exposed 
to A2 antisense oligonucleotides. In the presence of such oligo-
nucleotides, but not in the presence of scrambled-sequence 
oligonucleotides, distal dendritic delivery of PKM mRNA was 
significantly reduced (Fig. 3, E, F, and H). Second, we exam-
ined dendritic transport of PKM mRNA in which the 3 UTR 
noncanonical GA motif had been converted to canonical WC 
base pairing (Fig. S1). Fig. 5 shows that such mutants failed 
to be delivered to distal dendritic domains, in contrast to the 
WT PKM mRNA which clearly was. These results indicate 
that dendritic transport of PKM mRNA is mediated by hnRNP 
A2 and requires a noncanonical GA motif in a 3 UTR stem-
loop structure. The combined results suggest that the molecular 
mechanisms underlying dendritic transport of BC1 RNA and 
PKM mRNA are remarkably similar.
CGG triplet repeat competition
CGG triplets, expanded to 55–200 repeats, in the 5 UTR of 
FMR1 mRNA are causative of human premutation disorders in-
cluding FXTAS (Jacquemont et al., 2007; Brouwer et al., 2009; 
Hagerman et al., 2010). Such repeats form stem-loop structures 
that are stabilized by noncanonical G•G base pairs (Napierala   
et al., 2005; Zumwalt et al., 2007). Recent evidence suggests that 
CGG repeat stem-loop structures bind to hnRNP A2 (Sofola et al., 
2007; Swanson and Orr, 2007; Brouwer et al., 2009). We therefore 
hypothesized that noncanonical CGG repeat structures may com-
pete with noncanonical GA motifs that serve as DTEs. Such com-
petition would be expected to cause diminished GA motif binding 
to hnRNP A2 and, consequently, reduced dendritic delivery.
We performed two sets of experiments to test this hypoth-
esis. First, we examined binding of BC1 RNA to hnRNP A2 in 
are sharply bent conformations of GA motifs that serve as 
recognition sites for protein interactions (Goody et al., 2004; 
Lescoute et al., 2005). We therefore hypothesized that the affin-
ity for binding of BC1 RNA to hnRNP A2 may be a function of 
Mg
2+ ion concentrations. Titration curves in the presence of 
varying Mg
2+ concentrations confirmed that this was indeed the 
case (Fig. 2 C). At Mg
2+ concentrations of 10 mM or above, the 
Kd for BC1 RNA–hnRNP A2 binding was in the nanomolar 
concentration range (Kd = 8.2 nM at 10 mM Mg
2+, Kd = 3.5 nM 
at 25 mM Mg
2+). In contrast, at Mg
2+ concentrations <10 mM, 
the BC1 RNA–hnRNP A2 binding affinity was weaker by two 
orders of magnitude (Kd = 520 nM at 5 mM Mg
2+; Kd = 980 nM 
at 2.5 mM Mg
2+; Fig. 2 C). Thus, we observed a substantial in-
crease in binding affinity going from 5 mM to 10 mM Mg
2+.
An earlier study indicated that Mg
2+ and Ca
2+ ions are 
equivalent in their abilities to support the kinked conformation 
of ribosomal RNA KT motif KT-38 (Matsumura et al., 2003). 
We therefore asked whether the affinity for binding of BC1 RNA 
to hnRNP A2 is also modulated by Ca
2+ ions. Titration curves 
shown in Fig. 2 D show that the Kd for BC1 RNA–hnRNP A2 
binding underwent a shift of more than two orders of magni-
tude between 1 mM Ca
2+ (Kd = 210 nM) and 5 mM Ca
2+ (Kd =   
1.0 nM). Thus, although increasing Mg
2+ and Ca
2+ concentra-
tions both shifted BC1 RNA–hnRNP A2 equilibrium constants 
to higher affinities, this shift was induced at lower relative con-
centrations of Ca
2+ compared to Mg
2+.
In conclusion, the data show that high-affinity binding 
of BC1 RNA to hnRNP A2 requires a noncanonical 5 GA   
motif, and they suggest that interactions of the GA-type tar-
geting element with hnRNP A2 can be modulated in a Mg
2+/
Ca
2+-dependent manner.
Requirement of hnRNP A2 for  
dendritic targeting
We have previously shown that the apical noncanonical GA   
motif in the 5 BC1 domain is required for distal dendritic tar-
geting (Muslimov et al., 2006). With the results presented in this 
paper, we now show that this motif is specifically recognized 
by hnRNP A2, resulting in high-affinity, Mg
2+/Ca
2+-modulated 
binding. These data raise the question of whether interactions 
with hnRNP A2 are in fact necessary for the delivery of BC1 
RNA to distal dendritic domains.
We chose an antisense oligonucleotide approach to ad-
dress this question. We used antisense oligonucleotides di-
rected against the translational start site region of hnRNP A2, as 
described previously (Kwon et al., 1999; Munro et al., 1999). 
Exposure of sympathetic neurons in culture to such oligonucle-
otides resulted in a specific reduction of cellular levels of hnRNP 
A2 by >80% (Fig. S4). Cultured neurons exposed to A2 anti-
sense oligonucleotide were then examined for dendritic target-
ing of BC1 RNA, using our established microinjection paradigm 
(Muslimov et al., 1997, 2002, 2004, 2006). We observed a sig-
nificant reduction in distal dendritic targeting competence in the 
presence of A2 antisense oligonucleotides, but not in the pres-
ence of scrambled-sequence control oligonucleotides (Fig. 3, 
A–D and G). The data indicate that hnRNP A2 is required for 
distal dendritic targeting of BC1 RNA.JCB • VOLUME 194 • NUMBER 3 • 2011   446
Figure 3.  Dendritic transport of BC1 RNA and PKM mRNA is inhibited by hnRNP A2 antisense oligonucleotides. Photomicrographs show subcellular 
localization of injected full-length BC1 RNA (A and B) and PKM mRNA (E and F) in neurons pretreated with hnRNP A2 antisense oligonucleotides. BC1 
RNA and PKM mRNA were detectable in proximal but not distal dendritic domains. In contrast, BC1 RNA (C and D) and PKM mRNA (not depicted) were 
transported along the entire dendritic extent in neurons pretreated with scrambled-sequence oligonucleotides. Dark-field (left) and phase-contrast (right)   
images are shown. RNA signal appears as white silver grains in dark field images. Arrows indicate the extent of dendritic labeling. Number of cells ana-
lyzed: (A and B) 10 neurons, 34 dendrites; (C and D) 10 neurons, 30 dendrites; (E and F) 9 neurons, 31 dendrites. Bars, 50 µm. (G and H) Quantitative 
data are shown in the format of mean ± SEM of relative signal intensities along the dendritic extent for BC1 RNA (G) and PKM mRNA (H). One-way 
ANOVA, Dunnett’s post-hoc analysis (comparison of all interval points between A2 antisense and scrambled-sequence): P > 0.5 for interval points 50 µm, 
P < 0.001 for interval points 100 µm and beyond (for both BC1 RNA and PKM mRNA). Error bars indicate SEM.447 RNA codes in neuronal targeting • Muslimov et al.
Figure 4.  A2 antisense oligonucleotides cause long-term decrease in dendritic localization of endogenous BC1 RNA. (A and B) In situ hybridization experi-
ments reveal somato-dendritic localization of endogenous BC1 RNA in sympathetic neurons in culture. Dark field (A) and phase contrast (B) photomicro-
graphs show significant labeling for BC1 RNA along the dendritic extent. Dendrites are indicated by arrows, axons by red arrowheads. 8 neurons and 
26 dendrites were analyzed. In situ hybridization experiments using sense-strand control RNA probes did not result in any significant cellular labeling (not 
depicted). Subcellular distributions of other endogenous molecular components have been published earlier as follows: PKM mRNA (somato-dendritic; 
Muslimov et al., 2004), -tubulin mRNA (restricted to soma; Bruckenstein et al., 1990; Mohr et al., 2001), hnRNP A2 (somato-dendritic; Shan et al., 
2003; Smith, 2004). (C and D) After 1 h of exposure to A2 antisense oligonucleotides, dendritic localization of BC1 RNA remained indistinguishable from 
neurons maintained in the absence of oligonucleotides (A and B). Dendritic labeling is indicated by arrows. 9 neurons and 35 dendrites were analyzed. 
(E and F) After 24 h of exposure to A2 antisense oligonucleotides, a significant reduction was observed in dendritic (but not somatic) levels of endogenous 
BC1 RNA. Arrows indicate extent of the labeling signal. Red arrowheads in F indicate a morphologically identifiable axon. 12 neurons and 36 dendrites 
were analyzed. Scrambled-sequence oligonucleotides were not effective in reducing dendritic localization (not depicted). Bars, 50 µm. (G) Quantitative 
analysis of in situ hybridization data confirmed a significant reduction in the dendritic localization of BC1 RNA after 24 h (but not after 1 h) of treatment 
with A2 antisense oligonucleotides. The analysis also revealed that somatic levels of BC1 RNA increased after 24 h, though not after 1 h of A2 antisense 
treatment. One-way ANOVA, Dunnett’s post-hoc analysis: comparison of all interval points between 1 h A2 antisense and scrambled-sequence, P > 0.5 
for all interval points. Comparison of all interval points between 24 h A2 antisense and scrambled-sequence: P < 0.0001 for interval points 50 µm and 
beyond, P < 0.01 for interval points of 0 µm. Error bars indicate SEM.JCB • VOLUME 194 • NUMBER 3 • 2011   448
Figure 5.  A noncanonical GA motif in the 3 UTR is requisite for dendritic delivery of PKM mRNA. (A and B) WT PKM mRNA was transported along 
the entire dendritic extent, reaching distal dendritic tips. (C–F) In contrast, WC mutant PKM mRNA entered only proximal dendritic segments. Two differ-
ent WC mutants were used (see Fig. S1). Arrows indicate the extent of dendritic labeling. Number of cells analyzed: (A and B) 9 neurons, 30 dendrites;   
(C and D) 10 neurons, 32 dendrites; (E and F) 8 neurons, 29 dendrites. Bar, 50 µm. (G) Quantitative data were subjected to one-way ANOVA, Dunnett’s 
post-hoc analysis. Comparison of all interval points between WT and WC mutants: P > 0.5 for interval points 50 µm, P < 0.001 for interval points 100 µm   
and beyond (for both WC mutants, in comparison with WT). Error bars indicate SEM.449 RNA codes in neuronal targeting • Muslimov et al.
et al., 2007; Brouwer et al., 2009), the question arises of why, 
despite this adverse potential, normal-size repeats (< 55 CGG 
units) have been retained in the course of phylogenetic de-
velopment. Are they indispensable because they perform an es-
sential function?
We speculated that CGG repeats may in fact be determi-
nants of dendritic targeting. This speculation also takes into con-
sideration the observation that CGG repeats, analogous to GA 
targeting motifs, feature noncanonical purine•purine pairs that are 
flanked by standard WC GC pairs. We addressed this question   
by generating chimeric RNAs in which a (CGG)24 segment was 
inserted into the 5 UTR of -tubulin mRNA. This mRNA is nor-
mally nondendritic; i.e., it remains restricted to neuronal somata 
(Bruckenstein et al., 1990; Mohr et al., 2001). A 24-unit repeat 
was chosen to represent the subthreshold, “healthy” range of CGG 
repeats in FMR1 mRNA that is found in the normal population 
(Brouwer et al., 2009). Fig. 9 shows that (CGG)24 -tubulin RNA, 
but not (CCC)24 -tubulin RNA, was delivered to distal dendritic 
domains. The results indicate that CGG repeat stem loops can 
serve as spatial codes to specify dendritic RNA targeting.
RNA stability
A crucial determinant in RNA biology, specifically including 
RNA transport, is RNA stability. For this reason, we have in this 
and previous work taken extensive precautions to monitor the 
relative stability of transcripts (Materials and methods; Fig. S5;   
Muslimov et al., 1997, 2004, 2006). Such precautions are of   
utmost importance, as any introduced mutation, for instance in 
a DTE, may carry the risk of differentially affecting RNA stabil-
ity. This risk exists irrespective of the technique used to express 
nonnative RNAs in cells (i.e., injection, transfection of RNA or 
DNA constructs, or other). If a mutant RNA is inherently less 
stable than its WT counterpart, unreliable results will be ob-
tained no matter how the RNAs were introduced or expressed in 
cells. We therefore find it advisable that relative RNA stabilities 
be rigorously monitored in any RNA transport study.
the presence of (CGG)105 repeat RNA. A repeat length of 105 CGG 
units was chosen as premutation representative, which is consistent 
with previous work in the field (Jin et al., 2007; Sofola et al., 2007). 
We observed that (CGG)105 repeat RNA, but not (CCC)105 repeat 
RNA, effectively competed with binding of BC1 RNA to hnRNP 
A2 (Fig. 6). Second, we investigated the impact of (CGG)105 repeat 
RNA on dendritic targeting of BC1 RNA. In these experiments, 
we applied (CGG)105 repeat RNA at levels that we estimated were 
comparable to FMR1 mRNA levels in premutation disease cells 
(see Materials and methods). We found that under these conditions, 
distal dendritic delivery of BC1 RNA was significantly reduced in 
the presence of (CGG)105 RNA (Fig. 7). In contrast, (CCC)105 RNA 
had no effect on dendritic BC1 targeting (Fig. 7).
To corroborate that reduced dendritic targeting in the pres-
ence  of  (CGG)105  RNA  was  the  result  of  competition  with 
hnRNP A2, we performed rescue experiments in which recom-
binant hnRNP A2 was introduced into sympathetic neurons in 
culture by microinjection. At a molar ratio of 3:1 of injected 
hnRNP A2 to coinjected (CGG)105 RNA, dendritic transport of 
BC1 RNA was restored to a significant degree (Fig. 8). The data 
support the notion that CGG repeat RNA interferes with den-
dritic delivery of BC1 RNA by sequestering an essential shared 
component, hnRNP A2. It is also noted that although restoration 
of dendritic delivery by hnRNP A2 was significant, it was not 
complete (Fig. 8 G). It is possible that in addition to hnRNP A2, 
other trans-acting factors that are required for the dendritic tar-
geting of BC1 RNA are sequestered by CGG repeat RNA.
In conclusion, our results suggest that molecular competi-
tion of CGG triplet repeat RNA with the BC1 RNA GA target-
ing motif results in diminished hnRNP A2 binding and reduced 
distal dendritic delivery.
Role of CGG triplet repeats in  
RNA targeting
Given that CGG repeats in the 5 UTR of the FMR1 gene have 
the potential to expand and thus cause disease (Jacquemont 
Figure 6.  (CGG)105 RNA competes with BC1 RNA for binding to hnRNP A2. EMSA experiments were performed using native PAGE. (A) Increasing con-
centrations of (CGG)105 RNA reduced formation of BC1 RNA–hnRNP A2 complexes. (B) In contrast, (CCC)105 RNA showed no effect on BC1 RNA–hnRNP 
A2 interactions. hnRNP A2 was used at 100 nM, MgCl2 at 10 mM.JCB • VOLUME 194 • NUMBER 3 • 2011   450
In a similar vein, caution is urged when localization is 
investigated after expressing nonnative double-stranded RNAs 
over prolonged periods of time, as for instance in transgenic 
animals (Khanam et al., 2007). Cellular defense mechanisms 
may be activated in such cases (Kaufman, 2000; Pe’ery and 
Mathews, 2000), and tandem GA pairs within double-stranded 
RNA contexts are known to be particularly prone to elicit such 
responses (Bevilacqua et al., 1998).
Discussion
Translational control is a key mechanism in the regulation of 
gene expression in eukaryotic cells (Mathews et al., 2007). In 
neurons, the local translation of select mRNAs at synapto-dendritic 
sites plays an important role in the implementation of long-term 
neuronal  plasticity  (Job  and  Eberwine,  2001;  Kindler  et  al., 
2005; Jambhekar and Derisi, 2007; Miyashiro et al., 2009).   
Figure 7.  Dendritic delivery of BC1 RNA is significantly reduced in the presence of (CGG)105 RNA. (A and B) After coinjection with (CGG)105 RNA, transport 
of BC1 RNA along the dendritic extent was reduced. 6 neurons and 17 dendrites were analyzed. (C and D) In contrast, after coinjection with (CCC)105 
RNA, BC1 RNA was delivered along the dendritic extent, to distal-most dendritic segments and tips, in a manner indistinguishable from dendritic BC1 
transport in the absence of repeat RNA. 11 neurons and 35 dendrites were analyzed. Concentrations of (CGG)105 RNA and (CCC)105 RNA in the injection 
pipette were 1 µM. Arrows indicate the extent of dendritic labeling. Note that higher amounts of labeled RNA were injected in A and B (as compared with 
C and D) to verify that subcellular distribution (here somatic restriction) is independent of injection amounts (see also Materials and methods). Bar, 50 µm. 
(E) Data were examined by one-way ANOVA, Dunnett’s post-hoc analysis (comparison of all interval points between (CGG)105 RNA and (CCC)105 RNA): 
P > 0.5 for interval points 50 µm, P < 0.001 for interval points 100 µm and beyond. Error bars indicate SEM.451 RNA codes in neuronal targeting • Muslimov et al.
Figure 8.  Dendritic delivery of BC1 RNA is restored by hnRNP A2. (A and B) BC1 RNA was transported to dendritic domains after microinjection into 
sympathetic neurons in culture. 12 neurons and 36 dendrites were analyzed. (C and D) In the presence of (CGG)105 RNA, distal dendritic delivery of BC1 
RNA was significantly reduced (see also Fig. 7). 10 neurons and 29 dendrites were analyzed. (E and F) After coinjection with recombinant hnRNP A2   
(at a 3:1 molar ratio to (CGG)105 RNA), dendritic delivery of BC1 RNA was restored to a significant degree. 11 neurons and 38 dendrites were analyzed. 
Arrows indicate the extent of dendritic labeling. Bar, 50 µm. (G) Quantitative analysis confirmed that coinjection of hnRNP A2 with (CGG)105 RNA restored 
dendritic delivery of BC1 RNA to a significant degree. One-way ANOVA, Dunnett’s post-hoc analysis (comparison of all interval points between (CGG)105 
RNA and (CGG)105 RNA coinjected with hnRNP A2): P > 0.05 for interval points 50 µm, P < 0.0001 for interval points 100 µm and beyond. Error bars 
indicate SEM.JCB • VOLUME 194 • NUMBER 3 • 2011   452
transported to their subcellular destination sites (Smith, 2004; 
Bramham and Wells, 2007; Dahm et al., 2007). How is spatial 
information  encoded,  and  how  is  such  information  decoded 
through specific RNA motif recognition? Central to this question   
A major determinant of local protein-synthetic capacity, for ex-
ample at a synapse, is the availability of a specific set of RNAs 
at that site. Therefore, a fundamental question in neuronal gene 
expression is presented by the need for RNAs to be selectively 
Figure 9.  Chimeric (CGG)24 -tubulin RNA is transported to dendrites. (A and B) Microinjected chimeric (CGG)24 -tubulin RNA was specifically delivered 
to dendrites, reaching distal dendritic tips. 10 neurons and 33 dendrites were analyzed. Arrows indicate the extent of dendritic labeling. (C and D) In 
contrast, microinjected chimeric (CCC)24 -tubulin RNA failed to be transported along dendrites. 12 neurons and 36 dendrites were analyzed. Higher 
amounts of labeled RNA were injected in C and D to verify that somatic restriction is independent of injection amounts (see also Materials and methods). 
Bar, 50 µm. (E) Quantitative analysis: one-way ANOVA, Dunnett’s post-hoc analysis (comparison of all interval points between (CGG)24 -tubulin RNA and 
(CCC)24 -tubulin RNA): P < 0.0001 for interval points 50 µm and beyond. Error bars indicate SEM.453 RNA codes in neuronal targeting • Muslimov et al.
The possibility is thus raised that Ca
2+ may signal to dendritic 
RNA transport.
Ca
2+  transients,  including  intracellular  Ca
2+  waves  that 
originate in synaptic domains and propagate along the den-
drites toward the soma (Larkum et al., 2003; Berridge, 2009), 
are obvious candidates for such signaling, especially as local 
transient Ca
2+ increases can be significantly higher than global 
levels (Neher, 1998). Intracellular Mg
2+ surges that occur after   
depolarization (Kato et al., 1998; Gotoh et al., 1999) may also 
modulate hnRNP A2 interactions with cargo RNAs. In the intra-
cellular milieu, it is likely that additional proteins engage the 
targeting motif–hnRNP A2 complex (e.g., Pur; Johnson et al.,   
2006; Swanson and Orr, 2007), and that such assembly of 
RNA–protein ensembles will further fine-tune ion-dependent 
binding interactions and affinities.
CGG competition
In the RNA stem-loop GA motifs discussed here, noncanonical 
purine•purine pairings are requisite determinants for binding to 
hnRNP A2. Binding to hnRNP A2 has also been reported for 
CGG triplet repeat RNA motifs (Sofola et al., 2007; Swanson 
and Orr, 2007; Brouwer et al., 2009). CGG repeats form stem 
loops in which noncanonical G•G base pairs are flanked by 
standard WC GC pairs, resulting in stable RNA motif structures 
(Napierala et al., 2005; Zumwalt et al., 2007; Sobczak et al., 
2010). Collectively, these observations suggested that spatial 
code  GA  motifs  and  CGG  repeat  stem-loops  share  relevant 
structural features (i.e., GC-flanked noncanonical purine•purine 
pairs). We therefore hypothesized that such GA motifs and CGG 
repeat motifs may engage in a dynamic competition for an   
essential cellular resource, hnRNP A2. This hypothesis was cor-
roborated by experiments showing that (CGG)105 RNA, but not 
(CCC)105 RNA, effectively competed with BC1 RNA for bind-
ing to hnRNP A2, and that such CGG competition resulted in 
significantly reduced dendritic delivery.
CGG triplet repeats in the 5 UTR of the FMR1 gene are 
polymorphic (Jacquemont et al., 2007; Brouwer et al., 2009). 
In the normal population, CGG repeat lengths range from 5 up 
to 55, with an average length of 30 repeats (Fu et al., 1991). 
Intergenerational repeat instability may result in triplet expan-
sion to >55 CGG units. Repeat lengths of 55–200 CGG trip-
lets are causative of FXTAS and other premutation disorders, 
whereas repeat lengths of >200 CGG triplets, referred to as full 
mutation, are causative of FXS. In the first case, FMR1 mRNA 
with the 5 UTR CGG repeat expansion is expressed; in the 
second case, hypermethylation of the gene results in transcrip-
tional silencing (Brouwer et al., 2009). Thus, although FXS 
is a protein loss-of-function disease (resulting from functional 
absence of FMRP), FXTAS has been referred to as an RNA 
gain-of-function disease (Jacquemont et al., 2007; Brouwer 
et al., 2009; Hagerman et al., 2010). Expanded CGG repeats 
in the premutation range appear to precipitate “RNA toxicity” 
(Jacquemont et al., 2007; Hagerman et al., 2010), and it has 
been  suggested  that  partial  sequestration  of  cellular  factors   
(including hnRNP A2) by CGG repeat RNA may be an under-
lying cause of such toxicity (Iwahashi et al., 2006; Sofola et al., 
2007; Swanson and Orr, 2007; Oostra and Willemsen, 2009). 
is the recognition of RNA spatial destination codes by cognate 
trans-acting factors (Smith, 2004).
Noncanonical motif recognition
We report here that in one neuronal RNA transport pathway, 
such recognition is mediated by interactions of the trans- 
acting protein hnRNP A2 with RNA motifs that feature non-
canonical attributes. These motifs contain cores of noncanonical 
purine•purine base pairs. Tandem G•A/A•G pairs are often con-
tiguous with a variable internal loop featuring unpaired nucleo-
tides; in turn, this GA pair–internal loop element is flanked by 
standard WC pairs, often of the GC type. For the purpose of our 
analysis, we focused on one representative of dendritic regula-
tory RNAs (BC1 RNA) and on one representative of dendritic 
mRNAs (PKM mRNA).
We found that hnRNP A2 was required for the distal den-
dritic targeting of BC1 RNA and PKM mRNA. Conversion 
of GA motif noncanonical base pairs into standard WC base 
pairs prevented binding to hnRNP A2 and abolished distal den-
dritic targeting. Binding of BC1 RNA to hnRNP A2 was of high   
affinity, with a Kd in the nanomolar concentration range. A 
similar Kd has been reported for binding of hnRNP A2 to MBP 
mRNA, an mRNA that is localized in oligodendrocytes (Shan 
et al., 2000).
Remarkably, the binding affinity was exquisitely sensitive 
to concentrations of Mg
2+ and Ca
2+ ions. Relatively small con-
centration shifts—from 5 mM to 10 mM Mg
2+ or from 1 mM to 
5 mM Ca
2+—resulted in an increase in binding affinity by more 
than two orders of magnitude. We posit that such affinity shifts 
may have functional relevance. GA motifs exist in a dynamic 
equilibrium between an extended and a tightly kinked confor-
mation (Goody et al., 2004; Dennis and Omer, 2005; Lescoute 
et al., 2005). The kinked KT motif conformation is adopted at 
sufficiently high Mg
2+ or Ca
2+ concentrations in vitro (typically 
>5 mM; Matsumura et al., 2003; Goody et al., 2004; Schroeder 
et al., 2010), and the 5 BC1 domain is known to be kinked 
under these conditions (Muslimov et al., 2006). The data there-
fore suggest that the BC1 GA motif conformation is dimorphic and 
dependent on divalent cation concentrations, and that the kinked 
conformation is recognized by hnRNP A2 with higher affinity.
The GA motif transition from the extended to the kinked 
conformation appears to proceed via a hinge-like motion on a 
fast timescale (Cojocaru et al., 2005a,b; Rázga et al., 2005, 
2006). This “molecular-elbow” transition is promoted by the 
presence of divalent cations and by interactions with cognate 
proteins (Matsumura et al., 2003; Goody et al., 2004; Schroeder 
et al., 2010), two determinants that may act in concert (Turner 
et al., 2005). We suggest that brief, transient increases in local 
divalent cation availability may induce a rapid shift in the 
extended-kinked conformation equilibrium. Such a shift would 
allow cognate proteins to engage the motif at higher affinity, 
and possibly to lock the kinked conformation (Turner et al., 
2005). Although it remains to be established in future work how 
such conformational changes, induced by divalent cations, may 
impact dendritic targeting, recent data indicate that chelation of 
intracellular  Ca
2+  (using  BAPTA-AM)  results  in  diminished 
distal dendritic delivery of BC1 RNA (unpublished data).   JCB • VOLUME 194 • NUMBER 3 • 2011   454
However, supporting experimental evidence was not available 
(Brouwer et al., 2009).
Our  data  support  the  CGG-premutation  RNA  gain-of-
function hypothesis. GC-embedded noncanonical purine•purine 
RNA motifs are recognized by hnRNP A2, and such noncanon-
ical attributes are displayed both by CGG repeat stem loops 
and targeting-determinant GA motifs. We suggest that competi-
tion for hnRNP A2 establishes a dynamic equilibrium between 
FMR1 mRNA CGG stem loops and dendritic RNA GA motifs. 
At normal repeat lengths of 30 CGG units, this equilibrium 
would be “healthy,” whereas beyond the 55 CGG unit thresh-
old, hnRNP A2 binding would become unbalanced and skewed 
in favor of CGG repeat FMR1 mRNA. Increased CGG repeat 
lengths, coupled with significantly elevated levels of FMR1 
mRNA in premutation cells, appear to be sufficient to cause co-
sequestration of FMR1 mRNA and hnRNP A2 in nuclear inclu-
sions that are observed in FXTAS (Tassone et al., 2000, 2004; 
Iwahashi et al., 2006; Hagerman et al., 2010). As a result of 
these alterations, we suggest that transport-competent neuronal 
RNAs are becoming increasingly deprived of a trans-acting fac-
tor that is essential for their delivery to dendritic domains. We 
therefore put forward the hypothesis—and invite its further ex-
perimental scrutiny—that cellular RNA transport deficiencies 
are underlying CGG repeat premutation disorders.
Non-protein-coding neuronal brain cytoplasmic (BC) RNAs 
are mediators of translational control of gene expression and 
have been implicated in the local regulation of protein synthesis 
at the synapse (Kindler et al., 2005; Wang and Tiedge, 2009; 
Iacoangeli et al., 2010). Impaired dendritic delivery of BC200 
RNA has been observed in affected cortical areas of Alzheim-
er’s disease (AD) brains (Mus et al., 2007). It may therefore be 
tempting to speculate that BC RNA transport defects may be 
causally related to long-term neurodegenerative consequences 
that are observed in AD and FXTAS. However, there is one 
caveat, as dendritic transport not only of BC RNAs but also of 
relevant neuronal mRNAs may be negatively affected if levels 
of hnRNP A2 are reduced as a result of CGG repeat sequestra-
tion. Several neuronal mRNAs that bind to hnRNP A2 have been 
identified or predicted on the basis of structural features (Fig. 1; 
Munro et al., 1999; Muslimov et al., 2006; Tiedge, 2006; Gao 
et al., 2008). Currently, however, we are lacking a comprehen-
sive understanding of the complement of dendritic mRNAs that 
rely on hnRNP A2 for targeting. Impaired dendritic delivery 
of some of such hnRNP A2–dependent neuronal mRNAs may 
contribute to phenotypical manifestations in FXTAS and related 
premutation diseases. For example, we show that hnRNP A2 is 
required for dendritic delivery of PKM mRNA, and that a GA 
motif with internal loop and flanking GC pairs in the 3 UTR 
of the mRNA is requisite for recognition by hnRNP A2 and for 
dendritic transport. Future work will address the question of 
whether dendritic delivery of any such mRNAs is in competi-
tion with CGG repeat RNA.
Role of CGG motifs
An enigmatic aspect in trinucleotide repeat research has been 
the  question  of  why  such  repeats,  troublesome  once  ex-
panded, have been retained over the course of recent evolution 
(Brouwer et al., 2009). What functional benefits may they offer 
that make their continued presence indispensable? Prompted by 
our finding that CGG repeat motifs compete with GA targeting 
motifs for binding to RNA transport factor hnRNP A2, we sub-
sequently realized that such CGG RNA motifs can in fact func-
tion as spatial destination codes for dendritic delivery. These 
data further corroborate our hypothesis of a common denomina-
tor in CGG repeat codes and GA motif codes: WC-embedded 
noncanonical purine•purine pair motifs. We posit that standard 
size (30 units) CGG RNA stem-loop motifs and GA-type 
RNA targeting motifs are equal partners in dynamic competi-
tion for dendritic transport resources. CGG repeats that exceed 
a threshold (i.e., >55 CGG units) will become dominant and 
may outcompete relevant other neuronal RNAs for access to the 
essential transport resource hnRNP A2.
Materials and methods
Plasmids and RNA preparation
The following plasmids were used in this work: (1) pBCX607, to generate 
full-length WT BC1 RNA (Cheng et al., 1996; Muslimov et al., 1997); (2) 
pBC1IL-A:WC, to generate BC1 RNA in which noncanonical base pairs in the 
apical 5 domain have been replaced with standard WC pairs (Fig. S1; 
Muslimov et al., 2006); (3) pPKM-(48–1982), to generate transport-
competent segment nt 48–1982 of WT PKM mRNA (Muslimov et al., 2004); 
(4) pPKML-WC, equivalent to pPKM-(48–1982) except that noncanonical 
base pairs and unpaired nucleotides have been replaced with standard 
WC base pairs (mutant WC long, see Fig. S1); (5) pPKMS-WC, equivalent to 
pPKM-(48–1982) except that noncanonical base pairs in the 3 UTR have 
been replaced with standard WC base pairs, and unpaired nucleotides 
have been eliminated (mutant WC short, see Fig. S1); (6) pBC200, to gen-
erate full-length human BC200 RNA (Kondrashov et al., 2005); (7) pBSP, to 
generate a transport-competent segment of MBP mRNA (the plasmid was a 
gift from K. Ainger and J. Carson, University of Connecticut Health Center, 
Farmington, CT) and was constructed as a rat MBP SalI 666 to PvuII 953 
insert in pBluescriptII (SK+); (8) p(CGG)105, to generate (CGG)105 RNA; 
(9) p(CCC)105, to generate (CCC)105 RNA ((CGG)105 or (CCC)105 DNA 
was inserted into pBluescript SK (+) between the KpnI and DraII sites); (10) 
pSL300, to generate irrelevant random-sequence RNA (Muslimov et al.,   
1997); (11) p(CGG)24-tubulin, to generate (CGG)24 -tubulin chimeric 
RNA; (12) p(CCC)24-tubulin, to generate (CCC)24 -tubulin chimeric RNA: 
both DNA fragments ((CGG)24 -tubulin and (CCC)24 -tubulin) were cloned 
into pBluescript SK (+) between the XbaI and Asp718 sites; (13) pET-9c, 
to express recombinant full-length hnRNP A2 (plasmid was a gift from R. 
Smith, University of Queensland, Brisbane, Australia; Munro et al., 1999).
Plasmids were verified by sequencing. Plasmids 3, 4, 5, 11, and 12 
were linearized with XbaI, plasmid 7 with PvuII, plasmids 8 and 9 with DraII, 
plasmid 10 with KpnI, and all other plasmids with DraI. 
35S-labeled RNAs were 
generated by in vitro transcription, and size and integrity of all transcripts were 
ascertained by PAGE (Muslimov et al., 1997, 2002, 2004, 2006).
Expression of recombinant proteins
Recombinant hnRNP A2 was expressed and purified as described previ-
ously (Munro et al., 1999). In brief, recombinant protein was purified by 
chromatography on diethylaminoethyl cellulose (GE Healthcare), followed 
by chromatography on Sephacryl S-300 (GE Healthcare). Samples were 
further purified on a C4 reverse-phase HPLC column (Vydac) using a lin-
ear 10–50% acetonitrile gradient in 0.1% trifluoroacetic acid. Protein was   
lyophilized and finally dissolved in water. Identity and purity of hnRNP A2 
was established by SDS-PAGE and by electrospray mass spectrometry on 
a Sciex 165 spectrometer (PerkinElmer).
Recombinant eIF4G (central RNA-binding domain eIF4G737-1116) was 
generated from plasmid pET28(His6-eIF4GI737-1116) and purified by FPLC   
using a Mono S column (GE Healthcare). Linear gradients of 100 mM to 1 M 
KCl were used to elute eIF4G737–1116 at 290 mM KCl (Lin et al., 2008).
Native PAGE and EMSA
Native  PAGE  was  performed  in  8%  polyacrylamide  gels  (19:1  acryl-
amide/bisacrylamide) in 90 mM Tris-borate, pH 8.3, in the presence of 455 RNA codes in neuronal targeting • Muslimov et al.
or its derivatives under the experimental conditions used in this work 
(including hnRNP A2 antisense, CGG competition).
In addition, RNA stability was monitored by PAGE (Muslimov et al., 
1997, 2006). Fig. S5 shows that (CGG)105 RNA and (CCC)105 RNA did 
not significantly degrade when incubated with rat brain extract for up to 
4 h, the maximal incubation time used in RNA transport experiments. The 
data also show that (CGG)105 RNA and (CCC)105 RNA did not differ from 
each other in their relative stabilities when incubated with brain extract.
In  situ  hybridization  with  cultured  neurons  was  performed  with   
35S-labeled RNA probes (Muslimov et al., 1998, 2004).
Treatment of neurons with hnRNP A2 antisense oligonucleotides
Antisense  oligodeoxyribonucleotides  were  complementary  to  a  region 
containing the translational start site of hnRNP A2 (Kwon et al., 1999; 
Munro et al., 1999). Sympathetic neurons in culture were incubated in me-
dium containing 8 µM oligonucleotides (antisense or scrambled-sequence) 
for at least 18 h (Kwon et al., 1999; Munro et al., 1999; Shan et al., 
2003). Oligonucleotides were obtained from Sigma-Aldrich. hnRNP A2 
levels in treated neurons were established by Western blot analysis (Shan 
et al., 2003). Proteins were resolved by SDS-PAGE and were blotted onto   
Millipore Immobilon-P PVDF membranes (GenHunter). For development, a 
mouse antibody against a peptide segment in Exon 7 of hnRNP A2 (Ma 
et al., 2002) was used at 1:10,000 dilution. A rabbit antibody against 
-tubulin (Sigma Aldrich) was used as a control (1:2,000 dilution).
Microscopy and image analysis
A Microphot-FXA microscope (Nikon) was used for data acquisition (Muslimov 
et al., 2006). Neurons were imaged at room temperature using dark-field and 
phase-contrast optics. The following objective lenses were used: Plan-Fluor 
10×/0.30, 160 mechanical tube length/0.17 cover glass thickness; PhC Plan 
20×/0.50, DL 160/0.17; Plan 20×/0.50, differential interference contrast 
(DIC) 160/0.17; and Ph3 DL Plan 40×/0.65, 160/0.17. Digital images 
were acquired with a 5-megapixel charge-coupled device (CCD) camera 
(Digital Sight DS-Fi1; Nikon), or with a cooled CCD camera (CoolSNAP HQ, 
Roper Scientific). Image analysis was performed using MetaMorph software 
(Molecular Devices), and illustrations were generated using Photoshop and 
Illustrator software (Adobe). For further details, see Muslimov et al. (2006).
To establish RNA distribution profiles along dendrites, silver grain 
densities were measured along dendritic shafts at 50-µm interval points, up 
to a maximal distance of 300 µm (Muslimov et al., 2006). Signal intensities 
at 0-µm interval points (base of dendrites) were assigned a relative value of 
100; mean absolute signal intensities did not substantially differ at this inter-
val point between wild-type and respective mutant RNAs. Two to four den-
drites were analyzed per neuron (typically ≥10 neurons per experiment).
Statistical analyses were performed using SPSS software. All experi-
ments described in this work were performed at least four times, unless 
noted otherwise in figure legends. Error bars represent SEM.
Online supplemental material
Fig. S1 shows secondary structures of targeting-relevant domains in BC1 
RNA and PKM mRNA, and respective derivatives used in this work.   
Fig. S2 documents distal dendritic delivery of human BC200 RNA. Fig. S3 
provides additional confirmation that interactions of BC1 RNA and PKM 
mRNA with hnRNP A2 are specific. Fig. S4 verifies that application of hnRNP 
A2 antisense oligonucleotides results in reduced levels of hnRNP A2 in 
sympathetic neurons in culture. Fig. S5 documents comparable relative 
stabilities of (CGG)105 and (CCC)105 RNAs. Online supplemental material 
is available at http://www.jcb.org/cgi/content/full/jcb.201010027/DC1.
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Cell culture, RNA microinjection, and in situ hybridization
Primary cultures of sympathetic neurons were generated and maintained 
as described previously (Higgins et al., 1991; Muslimov et al., 1997, 
2004, 2006). In brief, superior cervical ganglia from embryonic day 19–21 
Sprague Dawley rat embryos were dissociated, and neurons were main-
tained on glass coverslips. Dendritic growth was induced by supplement-
ing the medium with basement membrane extract on the third day in vitro. 
1 µM cytosine arabinofuranoside was used on the second and fifth days 
after plating to minimize nonneuronal proliferation. Transport experiments 
were performed with neurons maintained in culture for 4 wk. Characteris-
tics of sympathetic neurons in primary culture have been described previ-
ously (Higgins et al., 1991). Work with animals was approved by the 
Institutional Animal Care and Use Committee.
Microinjection of radiolabeled RNA has been described previously 
(Muslimov et al., 1997, 2004, 2006). Our continued preference for this 
methodology has been motivated by the following considerations. (a) Radio-
labeled RNA was used for injection because it has been our experience that 
with nonradioactive labels (e.g., fluorescent and digoxigenin labels), the 
differential character of dendritic transport could not always be as clearly 
and reproducibly documented as with radiolabels. We believe that this may 
be caused by the fact that in complex RNA motifs (such as GA/KT motifs), 
most nucleotide interactions, particularly noncanonical ones, are indispens-
able and therefore exquisitely sensitive to steric hindrance by nonnative 
side groups. (b) Microinjection was preferred over other delivery methods 
because it allows unparalleled control over amounts of RNA introduced into 
cells (Muslimov et al., 2006). Over the past several years, microinjection 
has increasingly and routinely been used to introduce RNA into nerve cells 
(Shan et al., 2003; Schratt et al., 2006; Tübing et al., 2010).
RNAs were 
35S-radiolabeled at 3 × 10
6 cpm/µl and were micro-
injected into the perikaryal regions of sympathetic neurons in culture at 
volumes of a few femtoliters per pulse (Muslimov et al., 1997, 2006). We 
occasionally performed nuclear injections to check if nuclear experience of 
a transcript was targeting-relevant. No such case was observed. As before 
(Muslimov et al., 1997, 2006), we varied injection amounts over a con-
centration range of at least one order of magnitude to ensure that observed 
dendritic  targeting  patterns  were  concentration-independent.  (CGG)105 
and (CCC)105 RNAs were introduced at intracellular concentrations that 
were comparable to levels of FMR1 mRNA in premutation cells. Previous 
work (Tassone et al., 2000) has shown that normal expression levels of 
FMR1 mRNA are comparable to levels of -glucuronidase (GUS) mRNA, a 
commonly used PCR standard. In premutation cells, transcription of FMR1 
mRNA is strongly increased, resulting in expression levels that are elevated 
by a mean factor of eight for CGG repeat numbers of 100–200 (Tassone 
et al., 2000; Hagerman et al., 2010). With this information, we estimate 
that relative intracellular levels of (CGG)105 or (CCC)105 repeat RNAs, after 
microinjection into sympathetic neurons, were as follows. Low-amount injec-
tion routine: repeat RNA levels equivalent to or lower than (by a factor 
of at most four) premutation FMR1 mRNA levels. Medium-amount injection 
routine: repeat RNA levels equivalent to or higher than (by a factor of at 
most two) premutation FMR1 mRNA levels. High-amount injection routine: 
repeat RNA levels higher than (by a factor of at most six) premutation FMR1 
mRNA levels. Data from high-amount injection routine experiments are not 
presented in the figures and were not entered into quantitative analyses.
To monitor RNA stability, we assessed average integrated total sig-
nal intensities per injected cell for each transcript, as described previously 
(Muslimov et al., 2006). This intensity, i.e., the average sum of somatic and 
dendritic signal intensities, was used as an indicator of intracellular RNA 
stability after injection and over the period of incubation (Muslimov et al., 
2006). No significant differences were observed for a microinjected RNA JCB • VOLUME 194 • NUMBER 3 • 2011   456
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